The data obtained from measurements of re gional rCMRg1u using [ l 8F]fluorodeoxyglucose (FDG)/ positron emission tomographic (PET) data contain more structure than can be identified with group mean rCMRglu profiles or regional correlation coefficients. This addi tional structure is revealed by a novel mathematical-sta tistical model of regional metabolic interactions that ex plicitly represents rCMRgl U profiles as a combination of region-independent global effects, a group mean pattern and a mosaic of interacting networks. In its application to FDG/PET data, this model removes global subject effects [global scaling factors (GSFs)] and a group mean pattern (profile) so as to maximize statistical power for the detec tion and simultaneous discovery of all networks of two or more regions that form a significant and consistent
Summary:
The data obtained from measurements of re gional rCMRg1u using [ l 8F]fluorodeoxyglucose (FDG)/ positron emission tomographic (PET) data contain more structure than can be identified with group mean rCMRglu profiles or regional correlation coefficients. This addi tional structure is revealed by a novel mathematical-sta tistical model of regional metabolic interactions that ex plicitly represents rCMRgl U profiles as a combination of region-independent global effects, a group mean pattern and a mosaic of interacting networks. In its application to FDG/PET data, this model removes global subject effects [global scaling factors (GSFs)] and a group mean pattern (profile) so as to maximize statistical power for the detec tion and simultaneous discovery of all networks of two or more regions that form a significant and consistent Measurements of regional CMRglu (rCMRg\u) using [ l 8F]fluorodeoxyglucose (FDG) and positron emission tomography (PET) (Phelps et al., 1979) have been employed to study the metabolic re sponse of the brain to sensory stimulation (G reen berg et aI., 1981; Mazziotta et aI., 1982) , disease (Di Chiro et aI., 1982; Duara et aI., 1986; Yolkow et aI., 1986; Young et aI., 1986; Rottenberg et aI., 1987) , treatment (Patronas et aI., 1982; DeLisi et aI., 1985; Phillips et aI., 1987) and aging (Kuhl et aI., 1982; Duara et aI., 1984) . A major goal has been to dem-linearly covarying pattern. The model approach pre sented here was applied to the combined rCMRglu data from 12 demented AIDS patients and 18 normal controls: Two significant metabolic covariance pattern descriptors that together accounted for 71 to 96% of the rCMRglJ GSF variation across subjects for 22/28 regions in the AIDS group were extracted. Each descriptor was found to be highly correlated with performance on several neuropsychological tests, providing independent valida tion of the analysis technique as a means of discovering and describing behaviorally related components of group rCMRglu profiles. Key Words: AIDS-Fluorodeoxyglu cose-Positron emission tomography-Statistical Mod eling.
onstrate that the effects of neurologic disease can be identified as consistent pattern differences in the metabolic profiles of patients/ subjects versus normal controls.
Numerous attempts have been made to use simple statistical techniques, e.g., t tests and anal ysis of variance (ANOYA), and mean rCMRg\u values (or their differences) and/ or mean rCMRg\u ratios to define group-specific rCMRgiu patterns (Mazziota et aI., 1982; Haxby et aI., 1985; DeLisi et aI., 1985; Duara et aI., 1986; Young et aI., 1986) ; these approaches have had limited success in the face of small between-group differences and large intersubject variability (Mazziotta et al., 1982; Friedland et aI., 1985; Haxby et aI., 1985) . Never theless, several groups (Haxby et aI., 1985; Foster et aI., 1986; Young et aI., 1986) have shown that simple rCRMgl u differences and/ or ratios can be sig nificantly correlated with neuropsychological test scores, and recent studies have demonstrated sig nificant regional correlation or covariance patterns in groups of rCMRg\u profiles (Clark et aI., 1984; Metter et ai., 1984b, c; Horwitz et ai., 1984; Metter et ai., 1985; Clark et ai., 1985; Horwitz et ai., 1986; Volkow et ai., 1986; Clark et ai., 1986) . The appli cation of sophisticated statistical techniques, par ticularly correlation analysis, to the analysis of re gional inter-relationships in FDG/PET region-of interest (ROI) data has been hampered by both conceptual (Kennedy, 1985; Horwitz et aI., 1985; ) and methodological problems (Ford, 1986) .
In order to more accurately define the metabolic consequences of neuropsychological stimulation and neurologic disease, a new model-driven, math ematical-statistical approach to the analysis of FG D/PET data has been developed; this model (a) explicitly represents rCMRg\u profiles as a combina tion of region-independent global effects, a group mean pattern, and a mosaic of interacting net works; (b) removes region-independent global sub ject effects so as to maximize statistical power for the detection of region-dependent patterns; (c) permits the simultaneous discovery of all sets of two or more regions that form a significant and con sistent linearly covarying pattern after removal of global effects and a group mean pattern; and (d) uses descriptors of covariance patterns in a confir matory data analysis mode to discriminate between groups and to describe metabolic interactions with disease progression. The functional significance of derived regional interaction patterns in a group of demented AIDS patients has been established by correlating model descriptors of regional covari ance patterns with neuropsychological test scores.
THEORY
The sub profile scaling model (SSM) provides a decom position of subject profiles of normalized rCMRglu mea surements into a group mean profile (GMP) and subject residual profiles (SRPs), such that across subjects the re gional variation in SRPs reveals a covariance structure that has biological significance for the group. The SSM model assumes that an initial normalization of the indi vidual profiles of absolute rCMRglu by a subject-specific, region-independent global scaling factor (GSF) is re quired in order to recover this group-specific regional co variance structure. These ideas are expressed mathema tically in Eqs. I and 2 and graphically in Figures 1 and 2.
in which
In Eq. 1, GSFj is a scalar. The vector of GMPj values refers to normalized metabolic rates, i.e., to the mean of rCMRglu/GSFj for all subjects j, computed for each re gion i. F b r each subject j, the vector of SRPij values is the J Cereb Blood Flow Metab. Vol. 7, No. 5, 1987 residual pattern after GSFj and GMPj have been re moved. Although GMP and the SRPj are defined in terms of GSFj, it is Eq. 2 which uniquely determines the quan titative form of the subject GSF. SRPj are modeled as the vector sum of group invariant subprofiles (GISk), weighted by their subprofile scaling factors (SSFkj), for k = 1, 2, ... , K. Each GISk, like GMP, is a vector of regional values; however, unlike GMP, each GISk repre sents a covariance relationship among brain regions which is present to a greater or lesser degree in different subjects. In general, when a canonical representation of the SRPjj is used (Muirhead, 1982) , then the set of GISk, plus GMP, and the cardinality of the set represent an in variant property of the group metabolic profiles. The de scription of the distribution of the subject SSFkj also con stitutes a group property that can be correlated with other, independent measures of brain behavior.
Equation 2 constrains the GSFj of Eq. 1 to have a spe cific parametric form, that is defined as:
In Eq. 3a the In (GSF) are described in terms of the sum of djSSFkj, which are weighted by the parameters Ck, for k = 1, 2, ... , K, and In (GSFt), defined in Eq. 3b. The djSSF"j are SSM parameters, which are computed inde pendently of the GSFj and the Ck. The In (GSFt) are de fined by Bk and [In (rCRMglu)].j: Bk specify the particular weighted sum of djSSFkj that is the best least-squares predictor of [In(rCMRglu)].j . In(GSF*) is used as an ap proximation to the component of In(GSF) which is pair wise uncorrelated with every SSFk• The residual RESIDj is, in general, a nonlinear function of its arguments:
The last argument is functionally dependent on Ck. How ever, the above parametric form of GSF was derived so that when the % V AF by SRPij is small compared to the %VAF by GSFj in the total variation across rCMRglui i ,
I� -� J), � /2" �I\V g,: rL: RESIDj can be omitted without significantly affecting the fit of SSM to rCMRglu data. In SSM, the individual variations in GSFj and SRPjj are related to another principal measure of subject variation, GMRj: In log-transformed data, the "sum" of the SSM sources of subject variation equals the variation in GMRj. The algebraic sum of Eqs. 3a and 3b repre sents this partitioning of GMRj variation, in which Lt l (Ck -Bk)·�jSSFkj + RESIDj ] represents the con tribution of the variation of SRPij to GMRj.
When % VAF by SRPij is small compared to % V AF by GSFj, RESIDj is an order of magnitude smaller than [�l (Ck -Bk)·�jSSF kj ] (see Appendix). In this case, the approximation to In(GSF), obtained by omitting RESIDj, can be substituted into the partitioning of the variation of GMRj without significantly affecting the relative contri butions of GSFj and SRPij' In addition, the parameters Ck in the weighted sum of �jSSFk in Eq. 3a now specify the degree to which In(GSF) is correlated with different SSFk.
In the application of the SSM model an assumption is made regarding the size of the error in measuring (rCMRglu)ij' Measurement error is assumed to be inde pendently distributed across regions and profiles, and its standard deviation is assumed to vary in direct propor tion to the size of (GSFj x GMPJ, for each subject j and region i. Eq. 2 is thus modified to become K SRPjj = 2: (SSFkj x GISkJ + (GMPj x Eij), (2') k �l in which Ejj is normally distributed across all regions and subjects with a mean of zero and variance of one. This assumption ensures the necessary condition that, in random sampling, the standard error of the sample co variance (Ejj' SSFkj) for every combination of k and i con verges to zero as sample size increases.
METHODS

Patient and control groups
Details of the selection and testing procedures for pa tients and normal controls will be presented elsewhere (Rottenberg et aI., 1987) and are only summarized here. The patient group consisted of 12 demented AIDS pa tients aged 37 ± 6 years. They were studied over a 2-year period; one patient was studied twice. CT scans revealed varying degrees of atrophy but no focal atrophic or con trast-enhancing lesions. Eighteen volunteer subjects aged 27 ± 5 years served as a control population. All control subjects underwent a complete neurological examination and neuropsychological evaluation prior to FDG/PET scanning.
Neuropsychological evaluation
AIDS patients were evaluated on a series of 15 neuro psychological tests, which included confrontation naming (Kaplan et aI., 1983) , verbal fluency (Benton and Hamsher, 1976) , vocabulary and similarity judgments (Wechsler, 1981) , logical memory and visual reproduction (Wechsler, 1945) , serial and alternation problem-solving (Reitan, 1958) , digit-symbol substitution, digit span, vi suo spatial constructions (block design), grooved peg placement (Haaland and Delaney, 1981) , and finger-tap ping.
FDG/PET scanning FDG was produced according to Ginos et al. (1987) . PET scans were performed during a controlled resting state: Eyes were patched and auditory stimulation (music, intermittent verbal briefings) was delivered through acoustically-isolated earphones. Serial FDG/ PET images were acquired using the PC 4600 PET scanner (Kearfott and Carroll, 1984) , radial arterial blood was sampled at predetermined intervals, and compart mental rate constants and cerebral blood volume were calculated for 28 standardized gray-matter regions of in terest as described by Evans et al. (1986) (Fig. 3) . Indi vidual subject's mean rate constants, averaged across gray-matter regions of interest were used to "functiona lize" raw-count images acquired between 45 and 55 min after tracer injection, as described by Sokoloff et al. (1977) and Phelps et al. (1979) . In 4113 AIDS studies, se rial PET scans were not available, and a single 45-55 min scan was functionalized using average gray-matter rate constants obtained from the other nine studies. The rCMRglu value derived for each region of interest was the mean of functionalized pixel values in the upper 10% of the range from zero to the maximum pixel value within the region of interest.
Statistical analysis
All region-of-interest values were entered into a SAS (SAS Institute Inc., 1985) data-base for statistical anal ysis. Simple group descriptive statistics were compared for the AIDS patients and control group. The variation of logarithmically transformed rCMRg1u values was parti tioned into between-subject (SSb), within-subject (SSw), and subject residual (SSr) components, standard in re peated-measures designs (Clark et aI., 1985) . For each group, this partitioning was quantified in terms of the %VAF. In addition, the mean ± SD of the sub jects' global metabolic rates (GMRj = rCMRglu , for all subjects j) and the individual rCMRglu ;
. (for all r �gions i)
were calculated for each group; t tests were performed, and p < 0.05 significance levels incorporated the Bonfer roni correction for multiple comparisons.
In the application of SSM to FDG/PET data, subject data was organized into rCMRglu profiles of 28 regions, and AIDS and control profiles were analyzed as a single group. A principal component analysis was applied to the matrix of covariances between modified subject profiles, i.e., profiles in which the contributions of GSF and GMP were eliminated in the computation of the covariance terms. See Appendix for details of these computations.
Eigenvectors with significant sphericity statistics (Bartlett, 1954; Lawley, 1956; James, 1969) were used to compute the GISk and SSFk (see Appendix). GSFj was then computed from GISk and SSFk using Eqs. 3a and b. The best linear predictions of within-group variation in rCMRglu i j ( � for each group p and region i, based on GSF and fhe SSFk, were calculated as part of the GSF estimation procedure (see Appendix). Neuropsychological test scores for AIDS patients were correlated with three different metabolic measures of re gional activity for each region i: raw rCMRglu , rCMRglu j GMRj, and rCMRg1u /GSFj, Multiple regr�ssion pr � dictors of these sam� test scores were obtained using SSFkj as independent variables. Finally, GMRj and GSFj were correlated with test scores.
RESULTS
The wide range of absolute rCMRgiu values for the 12 AIDS patients (including one patient who was studied twice) and 18 normal controls is illus trated in Fig. 3 . rCMRg1u-versus-region-of-interest plots for normal controls (Fig. 3A) revealed (a) a consistent profile pattern across regions of interest and (b) substantially less between-subject variation in GMR than rCMRgiu variation across a subject profile. For the AIDS patients (Fig. 3B) , the profile pattern similarity was reduced and the GMR varia tion increased. These qualitative observations were quantified by partitioning the rCMRgiu profile varia tion (of log-transformed data) into SSb ' SSw, and SSr components: In the AIDS groups, SSb, SSw, and SSr account for 76, 14, and 10% of this varia tion versus 28, 56, and 16% in the control group. This result emphasizes the consistently small frac tion of rCMRgiu profile variation accounted for by SRPij and measurement error, which is equivalent to SSr'
Despite an apparent separation of AIDS and con trol mean rCMRgiu values across cortical regions, only two mean AIDS rCMRgiu values (left and right paracentral cortex) were significantly different from mean control values (p < 0.05). Mean GMR was not significantly reduced in ADC patients com pared to normal controls [5.64 ± 0.45 mg/min/100 g versus 6.48 ± 0.18, p > 0.1 by Student's t test al lowing for different variances (F = 4.42, p < 0. 006)].
The application of SSM to the combined-group dataset yielded two significant principal compo nents, represented by GISt and GIS2, which ac-count for 35 and 20% of the SRP variation, respec tively (p < 0. 01); nonsignificant third and fourth principal components account for 8 and 7% of the variance. Figure 4 illustrates the relative regions of interest weights for GISt and GIS2• For the AIDS group, mean SSF's for GISt and GIS2 were -0. 13 ± 0.13 (significantly different from 0.43 ± 0.09 for the control group, p < 0. 003) and 0.16 ± 0.14 (not significantly different from -0.09 ± 0. 07 for the control group, p > 0.2). Ta ble 1 indicates the extent GIS1, accounting for 35% of the subject residual profile (SRP) variance (A), and GIS2• accounting for 20% of the SRP variance (B). SRP variation of those brain regions joined with solid lines is well predicted (average R2 = 0.89) by a bilinear regression of SSF1 and SSF2 (see Table 1 ). whereas regions plotted as isolated points are not significantly correlated with SSF1 or SSF2 (p > 0.01). Note that the basal ganglia (regions of interest 20-21) and thalamus (regions of interest 25-26) are negatively correlated with all cortical regions in GIS1 and positively correlated with many cortical regions in GIS2• to which these SSFs predict regional variation in the SRPs for AIDS patients: based on significant correlation coefficients (p < 0.01), SSF1j and SSF2j are good predictors of SRPij variation for 22/28 re gions of interest. For the normal controls, a bilinear regression of SSFlj and SSF2j accounts for 61-92% of the intersubject variation in SRPij for the same 22/28 regions of interest. For the combined AIDS and normal groups, 29% of the GMRj variation of log-transformed data is accounted for by the varia tion in SSFlj and SSF2j. The mean GSFj of the AIDS group was 5. 83 ± 0. 38 versus 6. 20 ± 0.21 for the control group (p > 0. 35). GSFj were not significantly correlated (p > 0.2) with regional variation in SRPjj in either group.
Ta ble 2 lists the number of regions for which vari ation of absolute or normalized rCMRg1u across AIDS patients was significantly correlated (p < TABLE 1. Accuracy with which SSF1 and SSFz, the two GIS scaling fa ctors. predict the variation in three measures of regional metabolic activity in AIDS patients: rCMRg1uo rCMRg1jGMR, and rCMRg1jGSF. rCMR gj u• regional CMR g 1u; GMR. global metabolic rate; GSF, global scaling factor; SSF, subprofiJe scaling factor; L, left; R, right. For the region of interest code, see the legend to Figure 3. a p < 0.001 b P < 0.01 e p < 0.0001 0. 01) with the variation of neuropsychological test scores. More than three times as many significant correlations were produced by rCMRg1jGSF than by either rCMRgiu or rCMRg1jGMR. For rCMRg1j GSF, performance on 4/15 tests was significantly correlated with at least 15/28 region-of-interest values, and three other test scores were correlated with at least three region-of-interest values. All re gions that were significantly correlated with abso lute rCMRgiu were also correlated with rCMRglu/ GSF; however, normalization by GMR introduced new regional correlations. One test score (grooved peg placement) significantly correlated with GMRj (r = 0.55; p < 0.05), whereas GSFj was not corre lated with performance on any test (p > 0. 2).
Regions
Ta ble 3 illustrates the accuracy with which a linear combination of SSF1j and SSF2j predicts the interpatient variation for 15 different neuropsycho logical test scores. Significant correlations (p < 0. 05) were found for 4/15 test scores.
DISCUSSION
Previous statistical analyses of FDG/PET data
Most previous statistical analyses of FDG/PET data have searched for between-group differences in (a) absolute or normalized rCMRgiu profiles (D ' Antona et aI. , 1985; Duara et aI. , 1986; Chawluk et aI. , 1986) variance structure cannot be eliminated by stan dard data transformations, ANOVA inferential sta tistics provide, at best, insensitive tests for group differences and, at worst, introduce spurious "sig nificant" results (Kenny and Judd, 1986; O ' Brien and Kaiser, 1985) . This point has been made pre viously by .
The results of this study in combination with the evidence available in the literature from regional correlation analyses (Clark et aI. , 1984; Metter et aI. , 1984a, b; Horwitz et aI., 1984; Metter et aI., 1985; Clark et aI. , 1985; Clark et aI., 1986; Horwitz et aI., 1986; Volkow et aI., 1986) strongly suggest that analysis of rCMRgiu patterns should take into account the effects of regional covariation. Two types of covariance patterns have been analyzed: between regions and across subjects (Horwitz et aI., 1984) , and between subjects and across regions (Clark et aI. , 1985) . As noted below, the results of the former type of analysis are open to possible reinterpretation as a result of methodological errors related to the removal of global effects (Ford, 1986) .
Three previous studies describe the use of prin cipal component analysis or factor analysis. In a brief communication, Metter et ai. (1985) attempted to describe the rCMRgiu variability associated with Alzheimer ' s Disease, but provided little detail about their methods or results. Clark et ai. (1985) stressed the importance of finding a linear transfor mation that eliminates individual differences in the rCMRgiu profiles of normal subjects and used cluster analysis to quantify residual differences. In a study of schizophrenia by Volkow et al. (1986) , a factor analysis was performed on GMR-normalized profiles. As a result of this normalization, the re ported regions-of-interest pattern effects may have been distorted in a manner similar to that illustrated by our GMR-normalized AIDS data (Table 1) .
SSM
The SSM views the brain as a set of intercon nected but spatially distributed regions. The central assumption is that basal metabolic processes (Ken nedy, 1985) , attention, response to external stimuli, cognition, etc. , give rise to specific patterns of re gional metabolic covariation. Metabolic covariance patterns associated with different brain processes summate to produce individual SRPs. The group metabolic covariance patterns identified by SSM are the GISs (Figs. 2 and 4) , which represent dif ferent fixed covariance relationships (of metabolic activity) among brain regions.
The degree to which each GIS contributes to a rCMRg l u profile may vary considerably from sub ject to subject, and this variability is assumed to represent differential physiologic responsivity or, in the case of patient subjects, severity or progression of neurologic disease. In SSM, this variation is rep resented by subject-dependent SSFs which modu late the contribution of their corresponding GISs to the SRP (Fig. 2) .
As indicated by the partitioning of % VAF in the AIDS patients (see Results), the biologically rele vant information contained in the SRPs accounts for only a small percentage of the total metabolic variation of the group. Ta bles 1 and 3 present evi dence that the two significant independent GISs and their SSFs, as derived by SSM, are sufficient to predict (a) rCMRgiu values for individual AIDS pa tients (after normalization by GSF) and (b) patient performance on a series of standard neuropsycho logical tests. That these patterns correlate with neuropsychological test scores provides strong evi dence for the validity of SSM as a useful descrip tion of brain function as reflected in rCMRgiu da tasets.
Why SSM?
SSM incorporates a novel mathematical-statis tical model of regional metabolic interactions and a specific approach to the analysis of PET region-of interest data. A cardinal feature of SSM is its ex plicit separation of region-independent and region dependent subject effects. In the AIDS group, ei ther ignoring the contribution of the SSFkj to GMRj (column 3 of Ta bles 1 and 2) or ignoring the varia tion in GSFj (column 2, Ta bles 1 and 2) produced a small number of significant results in comparison to the much larger number obtained when both effects were quantified (column 4, Ta bles 1 and 2). If the GSFj of the AIDS rCMRgiu profiles were set equal to the respective GMRj in the application of the SSM model, then GIS1-which accounts for 35 %VAF-would not have been extracted. The re sults of this present study indicate that the separa tion of the subject variation in GMRj into the varia tion in GSFj (region-independent) and the variation in SSFkj (region-dependent) should not be ignored (Eqs. 3a and b). The confounding of these two sources of variation can create spurious, as well as diminished, differences both in between-group and within-group statistical comparisons. Our finding of a significant correlation between the mean meta bolic rate and the SD about that mean for each sub ject profile (r = 0.92, p < 0. 01), which is consistent with the correlation coefficient of 0.8 reported by Clark et al. (1985) , provides a rationale for the use of a multiplicative GSF.
Another important feature of SSM is its explicit representation of subject-region interactions as SRPs (Eq. 2 and Fig. 2 ) and the recognition that much clinically and/or biologically relevant infor mation is contained in this "small signal." Thus, in the AIDS group, SRP variation was correlated with 7/15 neuropsychological test scores, whereas GSF did not correlate with any test score. A third im portant feature of SSM is its power to extract sig nificant regional covariance patterns from small groups of subjects. This power derives, in part, from the use of combined groups for statistical analysis. The results of this study, obtained from a sample of 12 AIDS patients and 18 control subjects, suggest that Ford's caveat (1986): , "Even rigorous statistical approaches ... will be restricted by the small number of patients in experimental groups relative to the large number of possible intercorre lations," is unduly pessimistic.
As noted above, an arbitrary within-group co variance structure precludes the use of powerful AN OVA inferential statistics (O'Brien and Kaiser, 1985; Kenny and Judd, 1986) . Even the most gen eral approach to extracting regional differences among groups using a repeated measures design, multivariate analysis of variance (O'Brien and Kaiser, 1985) , does not permit the identification of group differences in covariance structures recover able by SSM.
The identification of individual differences through the use of cluster analysis (Clark et aI., 1985) represents a special case of the general situa tion modeled by SSM. The more general situation includes cases in which changes in the SRP covari-ance across subjects form a continuum for which there is no group clustering about several mean profiles. Such a concept of continuous pattern vari ation across subjects is required in order to estab lish metabolic correlates with, for example, contin uously varying neuropsychological performance or neurological examination scores.
In conclusion, SSM has proved effective in solving a fundamental problem of measurement created by attempts to eliminate region-indepen dent subject variation that does not affect the rela tive rCMRgiu profile across regions. This problem of initially removing a global effect common to all regions when analyzing FDG/ PET data is generic to analyses of covariance (Winer, 1971) . Ford (1986) identified the need to solve this measurement problem in his critique of the use of partial correla tions to eliminate global subject effects.
CONCLUSIONS
We have outlined a new model-driven, mathe matical-statistical approach to the analysis of PET region-of-interest data and have demonstrated, with reference to FDG/ PET scans of demented AIDS patients and normal control subjects, its ability to extract and identify functionally signifi cant metabolic rCMRgiu patterns. The results sug gest that (a) estimates of the global metabolic rate should not be used to remove [global] subject ef fects unless the global metabolic rate is equal to the GSF; (b) for most brain regions, the variation in SSM SSFs accurately describes the variation in ap propriatedly normalized rCMRgiu profiles; and (c) significant correlations exist between performance on specific neuropsychological tests and SSM met abolic descriptors.
Although the use of SSM with factor analysis in creases the computational complexity of PET data analysis, this approach permits the extraction and identification of regional cerebral metabolic inter actions in vivo and, in consequence, the elucidation of brain-behavior relationships in normal subjects and in pathological states. the respective rij, i.e., given the "small signal" ap proximation to SRPu' then r � -rio -roj
Principal component analysis is applied to the (epq) matrix to obtain estimates of LlJ GISki/GMPJs (the eigenvectors), LljSSFkj (the subject loading factors), and eigenvalues. SSFkj = Llj SSFkj' since SSFk. = O. In the AIDS analysis, the root-mean square of 100 [(Ll2 'Y ij/ Ll2rij) -1] is 8%-calculated across regions and subjects.
(e) In the estimation of GSF, a simple parametric form of GSFj is obtained by applying a "small signal approximation" to Eqs. 3a and b of the Theory section, i.e., by omitting RESIDj in Eq. 3a.
In the AIDS analysis, the best linear predictions of within-group variation in rCMRglu/ GSFj for the AIDS patients and control group were determined as a function of Ck. For each region i the predictor is a weighted sum of the SSFkj. The best estimates of Ck were defined as those that maximized the mean %VAFs obtained from the regression anal yses computed for individual regions i. In the AIDS data, neither C1 nor C 2 were significantly different from zero.
(f) After GSF is approximated by the procedure described above, the [GISk/GMP]. are estimated by finding the least-squares fit to the set of equations, lroj, for j = 1, 2, ... ,J . At this point, all the param eters of the SSM have been computed.
